Pharma Journalist -

Endo International plc announced that one of its operating companies, Par Pharmaceutical has received final approval from the U.S. Food and Drug Administration for its New Drug…
Read More...

Ferring Pharmaceuticals and Enteris BioPharma, Inc. announced that the companies have entered into a license agreement and initiated an early development agreement to leverage Enteris'…
Read More...

Mallinckrodt plc announced that it has entered into an agreement under which it will sell its Intrathecal Therapy business to Piramal Enterprises Limited's subsidiary in the U.K.,…
Read More...

Sanofi announced the appointment of Kathleen Tregoning as member of Executive committee, effective February 27, 2017. Ms. Tregoning will lead Sanofi’s External Affairs organization…
Read More...

uniQure announced that AMT-060,  its proprietary, investigational gene therapy in patients with severe hemophilia B, has received Breakthrough Therapy designation by the U.S. Food and…
Read More...

Mallinckrodt plc, a leading specialty pharmaceutical company, announced that it has closed the sale of its global Nuclear Imaging business to IBA Molecular (IBAM) for approximately $690…
Read More...

FDA has granted orphan drug designation for Vicore Pharma's drug candidates C21 for the treatment of IPF. C21 is thereby approved as an orphan drug in the USA. The approval brings C21…
Read More...

Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International, and a global drug discovery and development services company providing translational platforms to advance…
Read More...

Medtronic plc (MDT) announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to initiate a study of the IN.PACT Admiral…
Read More...

H. Lundbeck is partnering with IBM's Watson Health to sped up the development of new medicines for the treatment of psychiatric and neurological disorders. The collaboration will…
Read More...